Novel clinical features of recurrent human respiratory syncytial virus infections

Journal of Medical Virology

Volumn 86, Issue 9, 2014, Pages 1629-1638

  Yui, Ikuko ^a   Fujino, Motoko ^b   Sawada, Akihito ^c   Nakayama, Tetsuo ^c  

^a Yui Clinic   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Clinical characteristics; Human respiratory syncytial virus (HRSV); Repeated infections; Subgroup epidemiology

Indexed keywords

ANTIGEN DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE COURSE; DYSPNEA; EPIDEMIC; FEVER; GENE SEQUENCE; HUMAN; INFANT; JAPAN; LABORATORY DIAGNOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEWBORN; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; RECURRENT VIRUS INFECTION; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; BLOOD; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS;

VIRUS ANTIGEN;

AMBULATORY CARE FACILITIES; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; EPIDEMICS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LONGITUDINAL STUDIES; PROSPECTIVE STUDIES; RECURRENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84904039827     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23809     Document Type: Article

References (23)

1. De Paulis M, Gilio AE, Ferraro AA, Ferronato AE, do Sacramento PR, Botosso VF, de Oliveira DB, Marinheiro JC, Hársi CM, Durigon EL, Vieira SE. 2011. Severity of viral coinfection in hospitalized infants with respiratory syncytial virus infection. J Pediatr (Rio J) 87:307-313.
2. Galiano MC, Palomo C, Videla CM, Arbiza J, Melero JA, Carballal G. 2005. Genetic and antigenic variability of human respiratory syncytial virus (groups A and B) isolated over seven consecutive seasons in Argentina (1995-2001). J Clin Microbiol 43:2266-2273.
3. Glezen WP, Taber LH, Frank AL, Kasel JA. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546.
4. Hall CB, Kopelman AE, Douglas RG Jr, Geiman JM, Meagher MP. 1979. Neonatal respiratory syncytial virus infection. N Engl J Med 300:393-396.
5. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. 1990. Occurrence of groups A and B of respiratory syncytial virus over 15 years: Associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 162:1283-1290.
6. Hall CB, Walsh EE, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698.
7. Henderson FD, Collier AM, Clyde WA Jr, Denny FW. 1979. Respiratory syncytial-virus infections, reinfections and immunity: A prospective, longitudinal study in young children. N Engl J Med 300:530-534.
8. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
9. Matheson JW, Rich FJ, Cohet C, Grimwood K, Huang QS, Penny D, Hendy MD, Kirman JR. 2006. Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J Med Virol 78:1354-1364.
10. Miyairi I, DeVincenzo JP. 2008. Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 21:686-703.
11. Mufson MA, Belshe RB, Orvell C, Norrby E. 1987. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol 25:1535-1539.
12. Ooi LS, Ho WS, Ngai KL, Tian L, Chan PK, Sun SS, Ooi VE. 2010. Narcissus Tazetta Lectin shows strong inhibitory effects against respiratory syncytial virus, influenza A (H1N1, H3N2, H5N1) and B viruses. J Biosci 35:95-103.
13. Oshansky CM, Zhang W, Moore E, Tripp RA. 2009. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol 4:279-297.
14. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CR, Camargo E, Chanock RM. 1973. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 98:289-300.
15. Scott PD, Ochola R, Ngama M, Okiro EA, James Nokes D, Medley GF, Cane PA. 2005. Molecular analysis of respiratory syncytial virus reinfections in infants from Coastal Kenya. J Infect Dis 193:59-67.
16. Sullender WM, Mufson MA, Prince GA, Anderson LJ, Wertz GW. 1998. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infection in children. J Infect Dis 178:925-932.
17. Sullender WM. 2000. Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev 13:1-15.
18. Waris M. 1991. Pattern of respiratory syncytial virus epidemics in Finland: Two-year cycles with alternating prevalence of groups A and B. J Infect Dis 163:464-469.
19. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC Sr. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126-1136.
20. Yamaguchi M, Sano Y, Dapat IC, Saito R, Suzuki Y, Kumaki A, Shobugawa Y, Dapat C, Uchiyama M, Suzuki H. 2011. High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan. J Clin Microbiol 49:1034-1040.
21. Yui I, Hoshi A, Shigeta Y, Takami T, Nakayama T. 2003. Detection of human respiratory syncytial virus sequences in peripheral blood mononuclear cells. J Med Virol 70:481-489.
22. Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, Jones LP, Tripp RA. 2010. Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol 84:1148-1157.
23. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. 2007. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol 45:3022-3030.